The 'regulatory' β-subunit of protein kinase CK2 negatively influences p53-mediated allosteric effects on Chk2 activation

Oncogene

Volumn 24, Issue 40, 2005, Pages 6194-6200

  Bjørling Poulsen, Marina ^a   Siehler, Simone ^b   Wiesmüller, Lisa ^b   Meek, David ^c   Niefind, Karsten ^d   Issinger, Olaf Georg ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Chk2; CK2; p53; Phosphorylation; Protein kinase

Indexed keywords

CASEIN KINASE II; CHECKPOINT KINASE 2; PROTEIN KINASE B BETA; PROTEIN P53; PROTEIN SERINE THREONINE KINASE;

ALLOSTERISM; ARTICLE; BETA CHAIN; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME SUBSTRATE; ENZYME SUBUNIT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SEQUENCE ALIGNMENT; ANIMAL; CELL STRAIN COS1; CERCOPITHECUS; ENZYME ACTIVE SITE; GENETIC TRANSFECTION; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN BINDING; TUMOR SUPPRESSOR GENE;

ALLOSTERIC REGULATION; ANIMALS; CASEIN KINASE II; CATALYTIC DOMAIN; CERCOPITHECUS AETHIOPS; COS CELLS; ENZYME ACTIVATION; GENES, P53; HUMANS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 26944491156     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1208762     Document Type: Article

References (47)

1. Ahmed K, Gerber DA and Cochet C. (2002). Trends Cell Biol., 12, 226-230.
2. Ahn J, Urist M and Prives C. (2004). DNA Repair, 3, 1039-1047.
3. Appel K, Wagner P, Boldyreff B, Issinger OG and Montenarh M. (1995). Oncogene, 11, 1971-1978.
4. Bartek J, Falck J and Lukas J. (2001). Nat. Rev. Mol. Cell Biol., 2, 877-886.
5. Bartek J and Lukas J. (2003). Cancer Cell, 3, 421-429.
6. Bell S, Hansen S and Buchner J. (2002). Biophys. Chem., 96, 243-257.
7. Biondi RM and Nebreda AR. (2003). Biochem. J., 372, 1-13.
8. Boehden GS, Restle A, Marschalek R, Stocking C and Wiesmüller L. (2004). Carcinogenesis, 25, 1305-1313.
9. Boldyreff B and Issinger OG. (1997). FEBS Lett., 403, 197-199.
10. Boldyreff B, Meggio F, Pinna LA and Issinger OG. (1993). Biochemistry, 32, 12672-12677.
11. Cardenas ME, Dang Q, Glover CV and Gasser SM. (1992). EMBO J., 11, 1785-1796.
12. Chen M and Cooper JA. (1997). Proc. Natl. Acad. Sci. USA, 94, 9136-9140.
13. Chen M, Li D, Krebs ED and Cooper JA. (1997). Mol. Cell. Biol., 17, 1904-1912.
14. Craig A, Scott M, Burch L, Smith G, Ball K and Hupp T. (2003). EMBO Rep., 4, 787-792.
15. Daum JR and Gorbsky GJ. (1998). J. Biol. Chem., 273, 30622-30629.
16. Escargueil AE, Plisov SY, Filhol O, Cochet C and Larsen AK. (2000). J. Biol. Chem., 275, 34710-34718.
17. Farmer G, Bargonetti J, Zhu H, Friedman P, Prywes R and Prives C. (1992). Nature, 358, 83-86.
18. Ford HL, Landesmann-Bollag E, Dacwag CS, Stukenberg PT, Pardee AB and Seldin DC. (2000). J. Biol. Chem., 275, 22245-22254.
19. Goldberg Y. (1999). Biochem. Pharmacol., 57, 321-328.
20. Götz C, Scholtes P, Prowald A, Schuster N, Nastainczyk W and Montenarh M. (1999). Mol. Cell Biochem., 191, 111-120.
21. Grankowski N, Boldyreff B and Issinger OG. (1991). Eur. J. Biochem, 198, 25-30.
22. Guerra B, Götz C, Wagner P, Montenarh M and Issinger OG. (1997). Oncogene, 14, 2683-2688.
23. Guerra B and Issinger OG. (1999). Electrophoresis, 20, 391-408.
24. Guerra B, Issinger OG and Wang JY. (2003). Oncogene, 22, 4933-4942.
25. Guerra B, Siemer S, Boldyreff B and Issinger OG. (1999). FEBS Lett., 462, 353-357.
26. Huse M and Kuriyan J. (2002). Cell, 109, 275-282.
27. Kern SE, Kinzler KW, Bruskin A, Jarosz D, Friedman P, Prives C and Vogelstein B. (1991). Science, 252, 1708-1711.
28. Korn I, Gutkind S, Srinivasan N, Blundell TL, Allende CC and Allende JE. (1999). Mol. Cell Biochem., 191, 75-83.
29. Kusk M, Ahmed R, Thomsen B, Bendixen C, Issinger OG and Boldyreff B. (1999). Mol. Cell. Biochem., 191, 51-58.
30. Lehner B, Semple JI, Brown SE, Counsell D, Campbell RD and Sanderson CM. (2004). Genomics, 83, 153-167.
31. Litchfield DW. (2003). Biochem. J., 369, 1-15.
32. Lorenz P, Pepperkok R and Pyerin W. (1994). Cell. Mol. Biol. Res., 40, 519-527.
33. Luciani MG, Hutchins JR, Zheleva D and Hupp TR. (2000). J. Mol. Biol., 300, 503-518.
34. Meggio F, Boldyreff B, Marin O, Marchiori F, Perich JW, Issinger OG and Pinna LA. (1992). Eur. J. Biochem., 205, 939-945.
35. Niefind K, Guerra B, Ermakowa I and Issinger OG. (2001). EMBO J., 20, 5320-5331.
36. O'Neill T, Giarratani L, Chen P, Iyer L, Lee CH, Bobiak M, Kanai F, Zhou BB, Chung JH and Rathbun GA. (2002). J. Biol. Chem., 277, 16102-16115.
37. Pepperkok R, Lorenz P, Ansorge W and Pyerin W. (1994). J. Biol. Chem., 269, 6986-6991.
38. Povirk LF. (1996). Mutat. Res., 355, 71-89.
39. Prowald A, Schuster N and Montenarh M. (1997). FEBS Lett., 408, 99-104.
40. Schuster N, Götz C, Faust M, Schneider E, Prowald A, Jungbluth A and Montenarh M. (2001). J. Cell. Biochem., 81, 172-183.
41. Schwindling SL, Noll A, Montenarh M and Götz C. (2004). Oncogene, 23, 4155-4165.
42. Seo GJ, Kim SE, Lee YM, Lee JW, Hahn MJ and Kim ST. (2003). Biochem. Biophys. Res. Commun., 304, 339-343.
43. Soussi T and May P. (1996). J. Mol. Biol., 260, 623-637.
44. Stalter G, Siemer S, Becht E, Ziegler M, Remberger K and Issinger OG. (1994). Biochem. Biophys. Res. Commun., 202, 141-147.
45. Stigare J, Buddelmeijer N, Pigon A and Egyhazi E. (1993). Mol. Cell. Biochem., 129, 77-85.
46. Theis-Febvre N, Filhol O, Froment C, Cazales M, Cochet C, Monsarrat B, Ducommmun B and Baldin V. (2003). Oncogene, 22, 220-232.
47. Toczyski DP, Galgoczy DJ and Hartwell LH. (1997). Cell, 90, 1097-1106.